Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study

Journal of Medicinal Chemistry

Volumn 39, Issue 6, 1996, Pages 1227-1235

  Tafi, Andrea ^a   Anastassopoulou, Jane ^a   Theophanides, Theophile ^a   Botta, Maurizio ^b   Corelli, Federico ^b   Massa, Silvio ^b   Artico, Marino ^c   Costi, Roberta ^c   Di Santo, Roberto ^c   Ragno, Rino ^c  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF SIENA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIFONAZOLE; PYRROLE DERIVATIVE;

ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; FUNGUS GROWTH; GROWTH INHIBITION; HYDROPHOBICITY; HYDROXYLATION; MOLECULAR MODEL; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 13344282738     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950385+     Document Type: Review

References (44)

1. Cytochrome P-450 Structure, Mechanism and Biochemistry; Ortiz de Montellano, P. R., Ed.; Plenum Press: New York and London, 1986; references cited therein.
2. Akhtar, M.; Wright, J. N. A Unified Mechanistic View of Oxidative Reactions Catalysed by P-450 and Related FeContaining Enzymes. Nat. Prod. Rep. 1991, 8, 527-551.
3. Banting, L.; Nicholls, P. J.; Shaw, M. A.; Smith, H. J. In Progress in Medicinal Chemistry, V. 26; Ellis, G. P., West, G. B., Eds.; Elsevier Science Publishers, B.W.: Amsterdam, 1989; pp 253-298.
4. Vanden Bossche, H. In Sterol Biosynthesis Inhibitors Pharmaceutical and Agrochemical Aspects; Berg, D., Plentel, M., Eds.: Ellis Horwood: Chichester, England, 1988; pp 79-119.
5. Adams, J. L.; Metcalf, B. W. Therapeutic Consequences of the Inhibition of Sterol Metabolism. In Comprehensive Medicinal Chemistry, V. 2; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: Oxford, England, 1990: pp 333-364.
6. Hitchcock, C. A.; Dickinson, K.; Brown, S. B.; Evans, E. G. V.; Adams, D. J. Interaction of Azole Antifungal Antibiotics with Cytochrome P-450-Dependent 14α-Sterol Demethylase Purified from Candida albicans. Biochem. J. 1990, 266, 475-480.
7. Yeagle, P. L.; Martin, R. B.; Lala, A. K.; Lin, H. K.; Block K. Differential Effects of Cholesterol and Lanosterol on Artificial Membranes. Proc. Natl. Acad. Sct. U.S.A. 1977, 74, 4924-4926
8. 14DM Purified from Saccharomyces cerevisiae Microsomes. Biochem. Pharmacol. 1987, 36, 229-235
9. Goldman, R. C.; Klein, L. L. Problems and Progress in Opportunistic Infections In Annual Reports in Medicinal Chemistry, V. 29; Bristol, A. J., Ed.; Academic Press, Inc., San Diego, CA, 1994; pp 155-164.
10. Odds, F. C.; Schmid, J.; Soil, D. R. Epidemiology of Candida Infections in AIDS In Mycoses in AIDS Patients; Vanden Bossehe, H., Ed.; Plenum Press: New York, 1990; pp 67-74.
11. Yoshida, Y., Aoyama, Y. Yeast Cytochrome P-450 Catalyzing Lanosterol 14α-Demethylation. I. Purification and Spectral Properties J. Biol. Chem. 1984, 259, 1655-1660.
12. Hitchcock, C. A.; Dickinson, K.; Brown, S B.; Evans, E. G. V ; Adams, D. J. Purification and Properties of Cytochrome P-450-Dependent 14α-Sterol Demethylase from Candida albicans Biochem. J. 1989, 263, 573-579.
13. Trzaskos, J.; Kawata, S.; Gaylor, J. L. Microsomal Enzymes of Cholesterol Biosynthesis. Purification of Lanosterol 14α-Methyl Demethylase Cytochrome P-450 from Hepatic Microsomes. J Biol. Chem. 1986, 262, 14651-14657.
14. 14DM (Lanosterol 14α-Demethylase) from Pig Liver Microsomes Biochim. Biophys. Acta 1991, 1078, 388-394.
15. Morris, G M.; Richards, W. G. Molecular Modelling of the Sierol C-14 Demethylase of Saccharomyces cerevisiae. Biochem Soc. Trans. 1991, 19, 793-795.
16. Boscott, P. E.; Grant, G. H. Modeling Cytochrome P450 14α Demethylase (Candida albicans) from P450cam. J. Mol. Graphics 1994, 12, 185-192.
17. Hoeltje, H. D.; Hense, M. A Molecular Modeling Study on Binding of Drugs to Calmodulin. J. Comput.-Aided Mol. Des. 1989, 3, 101-109
18. Marshall, G. R; Cramer, R. D., III. Three Dimensional Structure-Activity Relationships. Trends Pharmacol. Sci. 1988, 9, 285-289.
19. Massa, S.; Di Santo, R.; Artico, M.; Costi, R; Di Filippo, C.; Simonetti, G.; Retico, A.; Artico, M. Researches on Antibacterial and Antifungal Agents. XV. 3-Aryl-4-[a-(1H-imidazol-l-yl)benzyl]-pyrroles with Potent Antifungal Activity. Eur. Bull. Drug Res. 1992, 1, 12-17.
20. Massa, S.; Di Santo, R., Retico, A.; Artico, M.; Simonetti, N.; Fabrizi, G.; Lamba, D. Antifungal Agents. Synthesis and Antifungal Activities of Estrogen-Like Imidazole and Triazole Derivatives. Eur. J. Med. Chem. 1992, 27, 495-502.
21. Massa, S.; Di Santo, R.; Artico, M.; Costi, R.; Apuzzo, G.; Simonetti, G.; Artico, M. Novel In Vitro Higly Active Antifungal Agents with Pyrrole and Imidazole Moieties. Med Chem. Res. 1992, 2, 148-153.
22. Massa, S.; Di Santo, R; Costi, R.; Simonetti, G.; Retico, A.; Apuzzo, G.; Artico, M. Antifungal Agents. III. Naphthyl and Thienyl Derivatives of 1H-Imidazol-1-yl-4-phenyl-1H-pyrrol-3-ylmethane. Farmaco 1993, 48, 720-736.
23. Artico, M.; Massa, S.; Di Santo, R.; Costi, A.; Retico, A.; Apuzzo, G ; Simonetti, N. Antifungal Agents. 5. Chloro and Amino Derivatives of 1,2-Diaryl-1-(1H-imidazol-1-yl)ethane with Potent Antifungal Activity. Eur. J. Med. Chem. 1993, 28, 715-720.
24. Di Santo, R.; Massa, S.; Costi, R.; Simonetti, G.; Retico, A.; Apuzzo, G.; Troccoli, F. Antifungal Agents. VIII. Synthesis and Antifungal Activities of Bipyrryl Analogues of Bifonazole. Farmaco 1994, 49, 229-236.
25. Polak, A.; Hartman, P. G. Antifungal Chemotherapy - Are We Winning? In Progress in Drug Research, V. 37; Jucker, E., Ed.; Birkhæuser Verlag. Basel, 1991; pp 181-269.
26. Fromtling, R. A. Imidazoles as Medically Important Antifungal Agents: an Overview. Drugs Today 1984, 20, 325-349.
27. Cramer, R. D., III; Patterson, D.; Bunce, J. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape in Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
28. Marchington, A. F. The Design of Triazole Fungicides. ACS Symp. Ser. 1984, 25, 173-183.
29. Furet, P.; Batzl, A.; Bhatnagar, E.; Francotte, E.; Rihs, G.; Lang, M. Aromatase Inhibitors: Synthesis, Biological Activity and Binding Mode of Azole-Type Compounds. J. Med. Chem. 1993, 36, 1393-1400.
30. Greco, G.; Novellino, E.; Fiorini, I.; Nacci, V.; Campiani, G.; Ciani, S. M.; Garofalo, A.; Bernasconi, P.; Mennini, T. A Comparative Molecular Field Analysis Model for e-Arylpyrrolo-[2,1-d][l,5]benzothiazepines Binding Selectively to the Mitochondrial Benzodiazepine Receptor. J. Med. Chem. 1994, 37, 4100-4108.
31. DePriest, S. A.; Mayer, D.; Naylor, C. B.; Marshall, G. R. 3D-QSAR of Angiotensin-Converting and Thermolysin Inhibitors: a Comparison of CoMFA Models Based on Deduced and Experimentally Determined Active Site Geometries. J. Am. Chem. Soc. 1993, 115, 5372-5384.
32. Marshall, G. R. Computer-Aided Drug Design. In Computer-Aided Molecular Design; Richards, G. R., Ed.; IBC Technical Services Ltd.: London, 1989; pp 91-104.
33. PCMODEL Molecular Modeling Software, available form Serena Software, Box 3076, Bloomington, IN 47402-3076.
34. Gajewski, J. J.; Gilbert, K. E.; McKelvey, J. MMX an Enhanced Version of MM2. In Advances in Molecular Modeling; Liotta, D., Ed.; JAI Press Inc.: Greenwich, London, 1990; Vol. 2, pp 65-92.
35. The program BKM is available from Professor Kosta Steliou, Boston University, Boston, MA.
36. Botta, B.; Di Giovanni, M. C.; Delle Monache, G.; De Rosa, M. C.; Gacs-Baitz, E.; Botta, M.; Corelli, F.; Tafi, A.; Santini, A.; Benedetti, E.; Pedone, C.; Misiti, D. A Novel Route to Calix[4]-arenes. 2. Solution- and Solid-State Structural Analyses and Molecular Modeling Studies. J. Org. Chem. 1994, 59, 1532-1541 and references cited therein.
37. The program MOPAC (Molecular Orbital Package) 5.0 is available from QCPE Creative Arts, Bldg. 181, Indiana University, Bloomington, IN, No. 455.
38. Sybyl (version 6 0) Molecular Modeling System, available from Tripos Associates Inc., 1699 S. Hanley Rd., St. Louis, MO 63144.
39. Stahle, L.; Wold, S. Partial Least Squares Analysis with Cross-Validation for the Two-Class Problem: a Monte Carlo Study. J. Chemom. 1987, 1, 185-196.
40. Cramer, R. D., III; Bunce, G. D.; Patterson, D. E.; Frank, I. E. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
41. Oprea, T.; Waller, C. L.; Marshall, G. R. Three-Dimensional Quantitative Structure-Activity Relationship of Human Immunodeficency Virus (I) Protease Inhibitors. 2. Predictive Power Using Limited Exploration of Alternate Binding Modes. J. Med. Chem. 1994, 37, 2206-2215.
42. Tafi, A.; et al. Unpublished results. Coordination of bifonazole to protoporphyrin was studied by modification the PCMODEL MMX force field, where the imidazole ring of bifonazole is bound perpendicularly to the heme group and gauche to one of the iron - nitrogen bonds in the porphyrin plane. The bond distance between the iron atom and the imidazole coordinating nitrogen N3, shown in Figures 1 and 2, is 2.00 Å. All the other bond distances and bond angles agree reasonably well with experimental structural data on heme enzymes reported up to date (see: Dawson, J. H.; Sono, M. Cytochrome P-450 and Chloroperoxidase: Thioiate-Ligated Heme Enzymes. Spectroscopic Determination of Their Active Site Structures and Mechanistic Implications of Thiotate Ligation. Chem. Rev. 1987, 87, 1255-1276).
43. Tafi, A.; et al. Unpublished results. Coordination of bifonazole to protoporphyrin was studied by modification the PCMODEL MMX force field, where the imidazole ring of bifonazole is bound perpendicularly to the heme group and gauche to one of the iron - nitrogen bonds in the porphyrin plane. The bond distance between the iron atom and the imidazole coordinating nitrogen N3, shown in Figures 1 and 2, is 2.00 Å. All the other bond distances and bond angles agree reasonably well with experimental structural data on heme enzymes reported up to date (see: Dawson, J. H.; Sono, M. Cytochrome P-450 and Chloroperoxidase: Thioiate-Ligated Heme Enzymes. Spectroscopic Determination of Their Active Site Structures and Mechanistic Implications of Thiotate Ligation. Chem. Rev. 1987, 87, 1255-1276).
44. 2 of 0.53 log unit. Due to this result, this approach was not considered further.